Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism
Zhenhua Dai, Qi Li, Yinong Wang, Ge Gao, Lonnette S. Diggs, George Tellides, Fadi G. Lakkis
Zhenhua Dai, Qi Li, Yinong Wang, Ge Gao, Lonnette S. Diggs, George Tellides, Fadi G. Lakkis
View: Text | PDF
Article

CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism

  • Text
  • PDF
Abstract

CD4+CD25+ regulatory T (Treg) cells suppress naive T cell responses, prevent autoimmunity, and delay allograft rejection. It is not known, however, whether Treg cells suppress allograft rejection mediated by memory T cells, as the latter mount faster and stronger immune responses than their naive counterparts. Here we show that antigen-induced, but not naive, Treg cells suppress allograft rejection mediated by memory CD8+ T cells. Suppression was allospecific, as Treg cells induced by third-party antigens did not delay allograft rejection. In vivo and in vitro analyses revealed that the apoptosis of allospecific memory CD8+ T cells is significantly increased in the presence of antigen-induced Treg cells, while their proliferation remains unaffected. Importantly, neither suppression of allograft rejection nor enhanced apoptosis of memory CD8+ T cells was observed when Treg cells lacked CD30 or when CD30 ligand–CD30 interaction was blocked with anti–CD30 ligand Ab. This study therefore provides direct evidence that pathogenic memory T cells are amenable to suppression in an antigen-specific manner and identifies CD30 as a molecule that is critical for the regulation of memory T cell responses.

Authors

Zhenhua Dai, Qi Li, Yinong Wang, Ge Gao, Lonnette S. Diggs, George Tellides, Fadi G. Lakkis

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Characterization of CD4+CD25+ Treg cells. (a) Freshly isolated spleen ce...
Characterization of CD4+CD25+ Treg cells. (a) Freshly isolated spleen cells from naive or DST-treated WT mice were stained for surface markers CD4, CD25, CD62L, CD45RB, CTLA4, and CD30 and analyzed in histograms after gating on the CD4+CD25+ T cell population. The dotted lines represent isotype control Ab, and the solid gray and black lines represent naive and DST-induced Treg cells, respectively. One representative experiment of three is shown. (b) Median fluorescence intensity of CD30 on DST Treg cells is higher than on naive Treg cells (*P < 0.05, ANOVA). (c) Freshly isolated spleen cells were also stained for intracellular cytokine expression of IL-2 and IL-10 after gating on CD4+CD25+ T cells. (d) Treg cells suppress anti-CD3–induced proliferation of CD4+CD25– T cells. Purified CD4+CD25+ Treg cells (3 × 104) were cultured with or without naive CD4+CD25– cells (6 × 104) in the presence of soluble anti-CD3 (1.0 μg/ml) and APCs (6 × 104) from BALB/c spleen cells for 72 hours. 50 U/ml of IL-2 was added to Treg cell culture alone to test whether the anergic status of Treg cells can be reversed. Results are presented as the mean of triplicate cultures.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts